BioStem Technologies

BSEMNasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$63.187 M

$3.54 -3.80%

Close of 21 Aug 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

17,849,471

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 161 →

#123ExozymesEXOZ$66.4M
#124Inmune BioINMB$64.4M
#125BioStem TechnologiesBSEM$63.2M
#126ImageneBioIMA$62.5M
#127MiNK TherapeuticsINKT$62.3M

Where these numbers come from

Share counts and financials for BioStem Technologies are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 21 Aug 2026. Read the methodology.